AVG
Ann Van Gysel
CEO at NewCo flanders.bio x Medvia
CEO
Description
Ann Van Gysel is the CEO of NewCo, a strategic alliance between flanders.bio and MEDVIA, dedicated to advancing innovation in healthcare and life sciences. With a PhD in Molecular Biology from Ghent University and postgraduate degrees in Business Management and Marketing, she has held key leadership positions at VIB and flanders.bio, where she played a pivotal role in driving growth and financial sustainability. She also founded Turnstone Communications and BioVox, providing strategic communications and business development expertise to the biotech and pharmaceutical industries.
Loading